Researchers in the Ludwig Center at the Johns Hopkins Kimmel Cancer Center report they have identified a drug treatment that could—if given early enough—potentially reduce the risk of death from the most serious complication of Coronavirus disease 2019 (COVID-19), also known as SARS-CoV-2 infection. Read the full news release
Posts by Clinton Petty:
When the coronavirus (COVID-19) stormed the U.S. in March, its swift spread took most of the country by surprise. Many felt frightened and unprepared, but armed with years of experience in taking on the most complex challenges, our Kimmel Cancer Center nursing team was ready. Cancer treatments often deplete immune cells, weakening the immune system, […]
The next On Target podcast is online. Today, Dr Akila Viswanathan speaks with Dr Phuoc Tran about his research into the spread of prostate cancer and a clinical trial that may show a response from the immune system for patients undergoing SBRT treatment. To read more about the ORIOLE Trial, click here: https://bit.ly/3ffj8WC
In this special edition of the On Target podcast, Dr Akila Viswanathan speaks with members of the Johns Hopkins Radiation Oncology COVID-19 response team about the protocols and patient procedures implemented throughout Johns Hopkins Medicine to ensure cancer patients continue to receive their care and remain safe from the Coronavirus.
In the next Sibley Integrative Podcast, Dr Rosanne Sheinberg and Harpreet Gujral explain the cancer-related risks associated with obesity and how the concept of NEAT (Non-exercise Activity Thermogenesis) plays a crucial role in maintaining a healthy weight.